MedTrace Logo

Implementation of an Asthma Program to Improve Asthma Identification and Education in Children

NCT01692080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 231

Last updated 2013-08-07

No results posted yet for this study

Summary

The primary objective of this study is to document the prevalence and associations between asthma, hypertension, and obesity in children living in Pittsburgh, Pennsylvania and its surrounding regions.

The secondary objective is to determine the impact of various educational interventions on child and caregiver knowledge of asthma.

Conditions

Interventions

BEHAVIORAL

Asthma education

Two separate asthma education classes are conducted to target two age groups: 6-10 yrs and 10-15 yrs. With the guidance of pharmacy faculty, student pharmacists develop innovative educational activities directed at three of the most common barriers to proper asthma control: avoidance of asthma triggers; compliance with asthma medications and proper usage of inhalers; and the importance of an asthma action plan. There is a different group of student pharmacists participating in each camp and this allows for variation in educational activities, all reinforcing the same important aspects of optimal asthma management. Students create age-appropriate activities for each group. Parents are required to attend camps with their child and participate in the asthma education sessions.

Sponsors & Collaborators

  • Pennsylvania Department of Health

    collaborator OTHER_GOV

  • Duquesne University

    lead OTHER

Principal Investigators

  • Jennifer P Elliott, PharmD · Duquesne University

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01692080 on ClinicalTrials.gov